References
- Tinkelman D G, Dejong R, Lutz C, Spangler D L. Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma. J Allergy Clin Immunol 1990; 85: 719–728
- Dulfano M J, Glass P. The bronchodilator effects of terbutaline: route of administration and patterns of response. Ann Allergy 1976; 37: 357–366
- Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta2-adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof): a study with salbutamol in asthmatics. Ant Rev Respir Dis 1977; 116: 861–869
- Tarala R A, Madsen B W, Paterson J W. Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol. 1980; 10: 393–397
- Ben-Zvi Z, Lam C, Hoffman J, Teets-Grimm K C, Kattan M. An evaluation of the initial treatment of acute asthma. Pediatrics 1982; 70: 348–353
- Inoue H, Inoue C, Okayama M, Sekizawa K, Hida W, Takishima T. Breathing 30 per cent oxygen attenuates bronchial responsiveness to inhaled methacholine in asthmatic patients. Eur Respir J 1989; 2: 506–512
- Walker S R, Evans M E, Richards A J, Paterson J W. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 1972; 13: 861–867
- Lenney W, Evans N AP. Nebulized salbutamol and ipratropium bromide in asthmatic children. Br J Dis Chest 1986; 80: 59–65
- Bacon C J. Nebulised salbutamol in treatment of acute asthma in children. Lancet 1978; 1: 158
- Harrison B A, Pierce R J. Comparison of wet and dry aerosol salbutamol. Aust N Z Med J 1983; 13: 29–33
- Davies D S. The fate of inhaled terbutaline. Eur J Respir Dis 1984; 65: 141–147
- Kemp J P, Pinnas J L, Tinkelman D G, Meltzer E O, Orgel H A, Welch M J, Mingo T S. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma. J Allergy Clin Immunol 1986; 77: 509–515
- Kradjan W A, Lakshminarayan S. Efficiency of air compressor-driven nebulizers. Chest 1985; 87: 512–516
- Walters E H, Cockroft A, Griffiths T, Rocchiccioli K, Davies B H. Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels. Thorax 1981; 36: 625–628
- Lipworth B J, Clark R A, Dhillon D P, Moreland T A, Struthers A D, Clark G A, McDevitt D G. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 1989; 37: 567–571
- Roels H, Malchaire J, Van Wambeke J P, Buchet J P, Lauwerys R. Development of a quantitative test for hand tremor measurement: study of factors influencing the response in a control population. J Occup Med 1983; 25: 481–487
- Lipworth B J, Brown R A, McDevitt D G. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta2-adrenoceptor blockade. Br J Clin Pharmacol 1989; 28: 95–102
- Hörnblad Y, Ripe E, Magnusson P O, Tegnér K. The metabolism and clinical activity of terbutaline and its prodrug ibuterol. Eur J Clin Pharmacol 1976; 20: 9–18
- Schaffler K, Reeh P W. Induction and reduction of muscle tremor upon acute and repeated administration of the beta2-agonists terbutaline, salbutamol and tulobuterol. Int J Clin Pharmacol Ther Toxicol 1987; 25: 673–682
- Collier J G, Dobbs R J, Williams I. Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol 1980; 9: 273–274
- Küng M, Croley S W, Phillips B A. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling. Chest 1987; 91: 382–387